Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Albertini

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant diseaseJ A Hank, M R Albertini, P M Sondel
Medical Oncology (Northwood, London, England)|March 14, 2000
Dermatomyositis after interferon alpha treatmentL L Dietrich, A J Bridges, M R Albertini
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Strategies for improving antitumor activity utilizing IL-2: preclinical models and analysis of antitumor activity of lymphocytes from patients receiving IL-2M R Albertini, J A Hank, P M Sondel
Cancer Letters|January 1, 1997
Tumor growth, weight loss and cytokines in SCID miceS Murray, K Schell, D O McCarthy, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Activation of multiple effector mechanisms to enhance tumor immunotherapyJ A Hank, M R Albertini, J Schiller, et al.
Cancer Gene Therapy|March 27, 2001
B7.1 expression eliminates tumor resistance to IL-12 gene therapyC P Heise, F Shi, M R Albertini, et al.
Mutation Research|May 5, 2001
In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patientsM R Albertini, D M King, M A Newton, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2000
Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expressionD O McCarthy, N Glowacki, K Schell, et al.
Cancer|June 1, 1995
Interleukin-2-induced splenic enlargementM A Pozniak, P S Christy, M R Albertini, et al.
Cancer Gene Therapy|May 1, 1996
Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transferM R Albertini, C A Emler, K Schell, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant diseaseJ A Hank, M R Albertini, P M Sondel
Medical Oncology (Northwood, London, England)|March 14, 2000
Dermatomyositis after interferon alpha treatmentL L Dietrich, A J Bridges, M R Albertini
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Strategies for improving antitumor activity utilizing IL-2: preclinical models and analysis of antitumor activity of lymphocytes from patients receiving IL-2M R Albertini, J A Hank, P M Sondel
Cancer Letters|January 1, 1997
Tumor growth, weight loss and cytokines in SCID miceS Murray, K Schell, D O McCarthy, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Activation of multiple effector mechanisms to enhance tumor immunotherapyJ A Hank, M R Albertini, J Schiller, et al.
Cancer Gene Therapy|March 27, 2001
B7.1 expression eliminates tumor resistance to IL-12 gene therapyC P Heise, F Shi, M R Albertini, et al.
Mutation Research|May 5, 2001
In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patientsM R Albertini, D M King, M A Newton, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2000
Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expressionD O McCarthy, N Glowacki, K Schell, et al.
Cancer|June 1, 1995
Interleukin-2-induced splenic enlargementM A Pozniak, P S Christy, M R Albertini, et al.
Cancer Gene Therapy|May 1, 1996
Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transferM R Albertini, C A Emler, K Schell, et al.
Pageof 3